<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="et al., 2013; Markland et al., 2000) 2. Ritonavir and" exact="lopinavir" post="SARS, MERS (Chu et al., 2004) 3. Ribavirin RSV"/>
 <result pre="1984) 4. Reverse transcriptase inhibitors: zidovudine, didanosine, zalcitabine, stavudine, lamivudine," exact="abacavir" post="and emtricitabine. SARS (De Clercq, 2007) 5. Nucleotide reverse"/>
 <result pre="emtricitabine. SARS (De Clercq, 2007) 5. Nucleotide reverse transcriptase inhibitor:" exact="tenofovir" post="disoproxil fumarate. SARS (De Clercq, 2007) 6. Non-nucleoside reverse"/>
 <result pre="(De Clercq, 2007) 6. Non-nucleoside reverse transcriptase inhibitors (NNRTIs): nevirapine," exact="delavirdine" post="and efavirenz. SARS De Clercq, 2007 7. Protease Inhibitors"/>
 <result pre="7. Protease Inhibitors (PIs): saquinavir, ritonavir, indinavir, nelfinavir, amprenavir, lopinavir," exact="atazanavir" post="and fosamprenavir. SARS De Clercq, 2007 8. Fusion inhibitor:"/>
 <result pre="by HIV protease. This drug along with another flu drug" exact="oseltamivir" post="was reported to result in complete recovery after showing"/>
 <result pre="2020b). 10.4 Remidesivir (anti-viral peptide) This particular drug is an" exact="adenosine" post="nucleotide analog, which was used in treatments against Ebola,"/>
 <result pre="Sun Yat-Sen University 17. A study for the efficacy of" exact="hydroxychloroquine" post="for mild and moderate COVID-19 infectious diseases Hydroxychloroquine –"/>
 <result pre="randomized, open-label, parallel controlled trial for the preventive effect of" exact="hydroxychloroquine" post="on medical personnel after exposure to COVID-19 Hydroxychloroquine –"/>
 <result pre="Ritonavir in the Treatment of Novel Coronavirus Infection Ganovo with" exact="ritonavir" post="+/-Interferon Recruiting The Ninth Hospital of NanchangNanchang, Jiangxi, China"/>
 <result pre="Minneapolis, Minnesota, United States 35. The efficacy and safety of" exact="pirfenidone" post="capsules in the treatment of severe new coronavirus pneumonia"/>
 <result pre="multiple effects on virus replication and propagation. Molecular basis of" exact="ribavirin" post="resistanceCurr. Opin. Virol.82014101510.1016/j.coviro.2014.04.01124846716 BeckB.R.ShinB.ChoiY.ParkS.KangK.Predicting commercially availableantiviral drugs that may"/>
 <result pre="and with clinical specimensJ. Clin. Microbiol.202010.1128/JCM.00310-20 CheemaS.U.R.RehmanM.S.HussainG.CheemaS.S.GilaniN.Efficacy and tolerability of" exact="sofosbuvir" post="and daclatasvir for treatment of hepatitis C genotype 1"/>
 <result pre="clinical specimensJ. Clin. Microbiol.202010.1128/JCM.00310-20 CheemaS.U.R.RehmanM.S.HussainG.CheemaS.S.GilaniN.Efficacy and tolerability of sofosbuvir and" exact="daclatasvir" post="for treatment of hepatitis C genotype 1 &amp;amp; 3"/>
 <result pre="fusionJ. Virol.8220082883289410.1128/JVI.01805-0718199653 HsiehL.E.LinC.N.SuB.L.JanT.R.ChenC.M.WangC.H.LinD.S.LinC.T.ChuehL.L.Synergistic antiviral effect of Galanthus nivalis agglutinin and" exact="nelfinavir" post="against feline coronavirusAntivir. Res.882010253010.1016/j.antiviral.2010.06.01020603153 HuF.JiangJ.YinP.Prediction of Potential Commercially Inhibitors"/>
 <result pre="in the viral replication cycleAntivir. Res.75200717918710.1016/j.antiviral.2007.03.00317428553 KeyaertsE.LiS.VijgenL.RysmanE.VerbeeckJ.Van RanstM.MaesP.Antiviral activity of" exact="chloroquine" post="against human coronavirus OC43 infection in newborn miceAntimicrob. Agents"/>
 <result pre="disease (COVID-19) infectionJ. Inf. Secur.202010.1016/j.jinf.2020.03.016 LewinsohnD.M.BowdenR.A.MattsonD.CrawfordS.W.Phase I study of intravenous" exact="ribavirin" post="treatment of respiratory syncytial virus pneumonia after marrow transplantationAntimicrob."/>
 <result pre="activity of the IMP dehydrogenase inhibitor VX-497: a comparison with" exact="ribavirin" post="and demonstration of antiviral additivity with alpha interferonAntimicrob. Agents"/>
 <result pre="McIntoshK.KurachekS.C.CairnsL.M.BurnsJ.C.GoodspeedB.Treatment of respiratory viral infection in an immunodeficient infant with" exact="ribavirin" post="aerosolAm. J, Dis. Child.13819843053086322573 MengelingW.WLM.ADB.AER.Characteristics of a coronavirus (strain"/>
 <result pre="resistance-inducing protein isolated from Clerodendrum inerme Gaertn. Is a polynucleotide:" exact="adenosine" post="glycosidase (ribosome-inactivating protein)FEBS Lett.39619961321348914973 OtakeT.MoriH.MorimotoM.UebaN.SutardjoS.KusumotoI.T.HattoriM.NambaT.Screening of Indonesian plant extracts"/>
 <result pre="with 2019 novel coronavirus–infected pneumonia in Wuhan, ChinaJama32320201061106910.1001/jama.2020.1585 WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
 <result pre="coronavirus SARS-CoV-2Eur. J. Nucl. Med. and Mol. Imaging20201610.1007/s00259-020-04735-9 YanY.ZouZ.SunY.LiX.XuK.-F.WeiY.JinN.JiangC.Anti-malaria drug" exact="chloroquine" post="is highly effective in treating avian influenza A H5N1"/>
 <result pre="the absence of growth factorsBiochem. J.392200513514310.1042/BJ2005069816048439 YaoT.T.QianJ.D.ZhuW.Y.WangY.WangG.Q.A systematic review of" exact="lopinavir" post="therapy for SARS coronavirus and MERS coronavirus-A possible reference"/>
</results>
